Monoclonal antibodies for medical oncology: a few critical perspectives.

Belda-Iniesta, Cristóbal; Ibáñez de Cáceres, Inmaculada; de Castro, Javier

Belda-Iniesta, Cristóbal; Ibáñez de Cáceres, Inmaculada; de Castro, Javier.

Affiliation

Belda-Iniesta C; Biomarkers and Experimental Therapeutics Group, IdiPAZ, University Hospital La Paz, Madrid, Spain. cbelda.hulp@salud.madrid.org

Clin Transl Oncol ; 13(2): 84-7, 2011 Feb.

Article in En | MEDLINE | ID: mdl-21324795

Subject(s)

Antibodies, Monoclonal/therapeutic use; Medical Oncology/trends; Neoplasms/therapy; Antibodies, Monoclonal/adverse effects; Antineoplastic Agents/adverse effects; Antineoplastic Agents/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Clinical Trials as Topic/methods; Clinical Trials as Topic/trends; Combined Modality Therapy; Humans; Immunotherapy/adverse effects; Immunotherapy/methods; Medical Oncology/methods; Neoplasms/drug therapy; Neoplasms/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Medical Oncology / Antibodies, Monoclonal / Neoplasms Type of study: Evaluation_studies Limits: Humans Language: En Journal: Clin Transl Oncol Year: 2011 Document type: Article Affiliation country: Spain Country of publication: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google